Epstein Secrets

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

19136788_UPDATE_20190811_193631.pdf Note Type: Status Management Department: Pathology DateTime: 08/11/2019 19:40 Entered By: Cms System Notes: NEW DC Note Type: Status Management Department: Mortuary Detonate?: 08/11/201918:11 Entered By: Notes: Check-Out Borough: Manhattan Note Type: FOS Tim

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

Status Management Department: Pathology Notes: 19136788_UPDATE_2019081 I _ 93631 .pdf Note Type: Status Management Department: Pathology Notes: NEW DC Note Type: Status Management Department: Mortuary Notes: Check-Out Borough: Manhattan Note Type: FOS Time out Department: Quality Assurance No

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n

19136788_UPDATE_20190811_193631.pcif Note Type: Status Management Department' Pathology DateTime: 08/11/2019 19:40 Entered By: Cms System Notes: NEW DC Note Type: Status Management Department Mortuary Notes: Cheek-Out Borough: Manhattan Note Type: FOS Time out Department: Duality Assurance Not